Table 5.
Sensitivity and specificity of QRDR mutations observed at least in 3 or more isolates and corresponding phenotypic resistance to ciprofloxacin for E. coli isolates. 1. Quinolone resistant-determining regions (QRDR) mutation. Chromosomal mutation gene and location; 2. Percent of isolates presenting the QRDR mutation profile from all isolate with phenotypic resistance to ciprofloxacin. The count of isolates with the QRDR mutation profile is in parenthesis; 3. Number of isolates with the referred QRDR mutation and phenotypic resistance to ciprofloxacin; 4. Number of isolates without the referred QRDR mutation and phenotypic resistance to ciprofloxacin; 5. Number of isolates with the referred QRDR mutation and without phenotypic resistance to ciprofloxacin; 6. Number of isolates without the referred QRDR mutation and without phenotypic resistance to ciprofloxacin; 7. Sensitivity for the referred QRDR mutation to correctly predict phenotypic antimicrobial resistance to ciprofloxacin; 8. Specificity for the absence of the referred QRDR mutation and prediction of lack of phenotypic resistance to ciprofloxacin.
| QRDR mutation profile1 | % (n) CIP R2 | G + : P + 3 | G−: P + 4 | G + : P−1 | G−: P−6 | Se7 | Sp8 |
|---|---|---|---|---|---|---|---|
| parC_239 gyrA_248 gyrA_259 gyrA_570 parE_1372 gyrA_468 gyrA_273 gyrA_255 gyrA_333 gyrA_300 | 75.3 (58) | 58 | 20 | 1 | 185 | 74.3 | 99.5 |
| parC_23 9gyrA_248 gyrA_259 gyrA_468 gyrA_273 gyrA_255 gyrA_333 gyrA_300 | 18.2 (14) | 14 | 64 | 1 | 185 | 17.9 | 99.5 |